Thermedical™, a medical equipment company developing new tissue-ablation therapies, announced on October 31, 2012, that it has received U.S. Food & Drug Administration (FDA) clearance to market its innovative technology for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures. Thermedical was awarded a $500,000 Small Business Matching Grant in 2010 from the MLSC.
